Filter Results:
(49)
Show Results For
- All HBS Web
(143)
- People (1)
- News (49)
- Research (56)
- Events (1)
- Multimedia (5)
- Faculty Publications (28)
Show Results For
- All HBS Web
(143)
- People (1)
- News (49)
- Research (56)
- Events (1)
- Multimedia (5)
- Faculty Publications (28)
Sort by
- 10 Dec 2018
- News
Did Free Pens Cause the Opioid Crisis?
- 01 Jun 2023
- News
Bridging the ESG Data Gap
Megan Murday The idea for a digital platform to help venture capitalists calculate, benchmark, and improve portfolio ESG performance crystallized while Megan Murday (MBA 2021) was studying at HBS. Now the CEO of the software startup Metric, she says that “investors... View Details
Keywords: Deborah Blagg
- 01 Jun 2024
- News
Quantum Leap
pharmaceutical and chemical industries have taken note: The venture capital arm of the pharma giant Merck, for instance, invested $5 million in SEEQC’s Series A round, where it was joined by the South Korean chemical company LG Chem,... View Details
- 29 May 2023
- News
Nurturing Breakthrough Ideas
As a center for creativity where innovation and entrepreneurship are intertwined, the Harvard Innovation Labs ecosystem encourages the development of novel ideas, approaches, and technologies that inspire new ventures or ways of thinking that keep companies relevant.... View Details
- 01 Jun 2023
- News
Cultivating Prosperity in Afghanistan
being a force for good and in the ability of a for-profit social enterprise to lay a sustainable foundation for our partners in Afghanistan to connect with people around the world.” “What better way to use our HBS education than for sustainable agriculture and business... View Details
Keywords: Jennifer Gillespie
- 01 Jun 2023
- News
An Engine of Innovation
Bridgitt Evans Executive Director, Harvard Innovation Labs NURTURING BREAKTHROUGH IDEAS From Big Pharma to Startup Cultivating Prosperity in Afghanistan Bridging the ESG Data Gap View Details
Keywords: Jennifer Gillespie
- 01 Dec 2013
- News
Your Own Medicine
fibrosis treatment. Williams got into pharma by chance. After working in investment banking before and after HBS, he took a job at the consulting firm Corporate Decisions (now Oliver Wyman). One of his first clients was launching a drug... View Details
- 01 Dec 2019
- News
The Race Against Resistance
with the rise of antibiotic-resistant superbugs. “We are approaching a cliff,” says Anna Diaz Triola (MBA 2000), vice president of marketing at Summit Therapeutics in Cambridge, Massachusetts, which is part of a cohort of small pharma... View Details
Keywords: Lisa Scanlon Mogolov
- 03 Oct 2019
- News
Clubs Convene to Focus on Health Care
as a retiree, investors, and entrepreneurs; alumni working in a range of health care sectors, from biotech and research to pharma and the provider side of it as well. It was a chance to get connected. There was no agenda and no speaker.... View Details
- 01 Mar 2016
- News
Off Script
top posts at Schering-Plough and Wyeth. Are there structural reforms that could be implemented in the drug industry to lower the market-driven price of drugs? Forcing pharma firms to invest in R&D a minimum percentage of the sales of any... View Details
- 01 Dec 2004
- News
Finding a Balance
pirate by global pharmas that consider Cipla’s products a direct rip-off of patented drugs. From 1999 through 2002, Cipla enjoyed an average annual growth rate of 30.3 percent from the sale of more than 400 drugs, including generic... View Details
- 25 Jun 2020
- News
Covering All Corners
the pharmaceutical needs of emerging markets and has a strong presence in more than 40 countries throughout Africa and the Middle East-North Africa region. “We are a very purpose-driven team and believe in empowering the fight for health and wellbeing as a human... View Details
- 01 Aug 2013
- News
A Cure for Cold Storage
wins, combined with a July 2012 paper that detailed the science behind the technology, attracted attention from the likes of the Economist and National Public Radio. Soon, Schrader no longer had to cold call the pharma companies—they were... View Details
- 01 Mar 2023
- News
The Latest Model
was booming: The price of bitcoin had surged to nearly $20,000; governments were beginning to recognize the cryptocurrency as legal tender; and industries from fintech to pharma were launching blockchain-related projects. (Though best... View Details
- 16 Nov 2021
- News
Getting Back Together for Global Networking Night; Healthcare Conference Draws New Interest
pillars of health care in terms of the sectors, so we had pharma and biotech as one group, digital and IT, Investment, and then care providers,” says HBSHAA copresident Nicki MacManus (MBA 2009). “And there’s more and more interest in... View Details
Keywords: Margie Kelley
- 01 Mar 2007
- News
Daniel Vasella
years the growth rate of the vaccine industry will be between 15 and 20 percent, making it a very attractive industry. The margins are, again, not as high as in patented, branded products, but they still are quite attractive. Also, one of the reasons why big View Details
- 23 Jan 2019
- News
The Promise of Personalized Medicine
end of the day, it’s the people that give me hope, that they’re there for the right reasons. Pharma nowadays gets a lot of negative press at pricing and things like that. It’s tough to say, but I don’t think that’s characteristic of the... View Details
- 19 Aug 2024
- News
Quantum Leap
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Hi, this is Dan Morrell, host of Skydeck. Quantum computing has long been talked about as one of the next big things—the kind of technology, like AI, that will change everything. But to our... View Details